This report presents detailed results on the quality of regulatory management systems, following the survey conducted in 2005-6. The goal of this report is to compare regulatory quality assurance systems; to measure progress and understand trends over time across countries, and to identify...

Regulatory impact analysis (RIA) is a systemic approach to critically assessing the positive and negative effects of proposed and existing regulations and non-regulatory alternatives. This publication brings together recent OECD research and analysis concerning methodological issues and country...

Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care...